Skip to main content
. 2017 Feb 26;23:1026–1032. doi: 10.12659/MSM.900383

Table 4.

Prognosis of patients who developed more severe pancreatitis or not.

Total patients (n=602) MSAP or SAP develop (n=74) Still with MAP (n=528) P
Hospital duration (days) 10±4 21±5 8±3 .022
Mortality (n, %) 4 (0.66%) 4 (5.4%) 0 .015
ICU transfer 20 (3.32%) 20 (27.0%) 0 <.001

P value: “Progression to MSAP or SAP group” versus “MAP only group”.